8.3255
price down icon5.21%   -0.4845
 
loading
Precedente Chiudi:
$8.81
Aprire:
$8.85
Volume 24 ore:
1.16M
Relative Volume:
0.49
Capitalizzazione di mercato:
$1.07B
Reddito:
$628.25M
Utile/perdita netta:
$-78.55M
Rapporto P/E:
-13.43
EPS:
-0.62
Flusso di cassa netto:
$-29.73M
1 W Prestazione:
+17.95%
1M Prestazione:
+61.84%
6M Prestazione:
-12.83%
1 anno Prestazione:
-47.38%
Intervallo 1D:
Value
$8.30
$8.85
Intervallo di 1 settimana:
Value
$6.945
$9.06
Portata 52W:
Value
$4.72
$19.11

Neogenomics Inc Stock (NEO) Company Profile

Name
Nome
Neogenomics Inc
Name
Telefono
(239) 768-0600
Name
Indirizzo
9490 NEOGENOMICS WAY, FORT MYERS, FL
Name
Dipendente
2,200
Name
Cinguettio
@NeoGenomics
Name
Prossima data di guadagno
2025-02-18
Name
Ultimi documenti SEC
Name
NEO's Discussions on Twitter

Confronta NEO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
NEO
Neogenomics Inc
8.32 1.13B 628.25M -78.55M -29.73M -0.62
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
481.81 186.06B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
200.95 147.38B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
626.86 51.77B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
123.98 35.62B 6.79B 1.22B 1.09B 4.26
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
181.48 32.44B 15.70B 1.24B 2.01B 6.91

Neogenomics Inc Stock (NEO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-30 Downgrade BTIG Research Buy → Neutral
2025-07-29 Downgrade William Blair Outperform → Mkt Perform
2025-05-15 Iniziato Guggenheim Neutral
2025-04-30 Downgrade Leerink Partners Outperform → Market Perform
2025-01-13 Downgrade The Benchmark Company Buy → Hold
2024-12-10 Iniziato Jefferies Buy
2024-05-01 Ripresa Craig Hallum Buy
2023-12-29 Reiterato BTIG Research Buy
2023-08-21 Aggiornamento Stephens Equal-Weight → Overweight
2023-05-16 Downgrade Raymond James Outperform → Mkt Perform
2023-05-09 Aggiornamento BTIG Research Neutral → Buy
2023-02-24 Aggiornamento The Benchmark Company Hold → Buy
2023-02-01 Aggiornamento Needham Hold → Buy
2022-08-26 Downgrade The Benchmark Company Buy → Hold
2022-08-22 Downgrade Needham Buy → Hold
2022-06-03 Iniziato Piper Sandler Overweight
2022-03-29 Downgrade BofA Securities Buy → Neutral
2022-03-29 Downgrade Stephens Overweight → Equal-Weight
2022-01-18 Ripresa Stephens Overweight
2021-12-16 Iniziato Cowen Outperform
2021-11-05 Downgrade Morgan Stanley Overweight → Equal-Weight
2021-10-14 Aggiornamento Raymond James Mkt Perform → Outperform
2021-06-03 Iniziato Goldman Buy
2021-02-25 Ripresa Needham Buy
2021-02-25 Downgrade Raymond James Outperform → Mkt Perform
2021-01-28 Iniziato Truist Buy
2020-12-11 Ripresa BTIG Research Buy
2020-10-28 Reiterato Needham Buy
2020-09-09 Iniziato Morgan Stanley Overweight
2020-08-28 Iniziato Guggenheim Buy
2020-07-29 Reiterato Needham Buy
2020-06-25 Iniziato BofA/Merrill Buy
2020-04-21 Ripresa Stephens Overweight
2020-03-02 Ripresa Craig Hallum Buy
2020-02-28 Aggiornamento First Analysis Sec Outperform → Strong Buy
2020-01-23 Downgrade First Analysis Sec Strong Buy → Outperform
2019-10-30 Reiterato Needham Buy
2019-05-01 Reiterato Needham Buy
2019-03-29 Reiterato Needham Buy
2019-01-03 Iniziato Needham Buy
2018-10-24 Aggiornamento First Analysis Sec Outperform → Strong Buy
2018-08-21 Iniziato Leerink Partners Outperform
2018-05-02 Downgrade First Analysis Sec Overweight → Equal-Weight
2017-09-11 Downgrade BTIG Research Buy → Neutral
2017-08-24 Iniziato Gabelli & Co Buy
2016-12-15 Iniziato Cantor Fitzgerald Overweight
Mostra tutto

Neogenomics Inc Borsa (NEO) Ultime notizie

pulisher
07:21 AM

Published on: 2025-09-03 06:21:26 - Newser

07:21 AM
pulisher
06:58 AM

Has NeoGenomics Inc. found a price floorQuarterly Earnings Summary & Free Accurate Trade Setup Notifications - Newser

06:58 AM
pulisher
06:34 AM

What data driven models say about NeoGenomics Inc.’s futureMarket Trend Review & Safe Swing Trade Setup Alerts - Newser

06:34 AM
pulisher
05:07 AM

Ranking NeoGenomics Inc. among high performing stocks via toolsGap Down & Free Long-Term Investment Growth Plans - Newser

05:07 AM
pulisher
04:57 AM

Using Python tools to backtest NeoGenomics Inc. strategiesQuarterly Trade Report & Precise Trade Entry Recommendations - Newser

04:57 AM
pulisher
03:56 AM

When is the best time to exit NeoGenomics Inc.July 2025 Market Mood & Fast Exit and Entry Strategy Plans - Newser

03:56 AM
pulisher
02:35 AM

Is NeoGenomics Inc. meeting your algorithmic filter criteriaJuly 2025 Review & Technical Pattern Recognition Alerts - Newser

02:35 AM
pulisher
02:32 AM

Is now a turning point for NeoGenomics Inc.2025 Support & Resistance & Fast Gain Swing Alerts - Newser

02:32 AM
pulisher
Sep 02, 2025

Does NeoGenomics Inc. qualify in momentum factor screeningPrice Action & Precise Trade Entry Recommendations - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Chart based analysis of NeoGenomics Inc. trendsTrend Reversal & AI Forecast Swing Trade Picks - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Does NeoGenomics Inc. have a sustainable dividendTrade Analysis Report & Risk Managed Investment Strategies - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Applying sector rotation models to NeoGenomics Inc.July 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What is NeoGenomics Inc. s debt to equity ratioJuly 2025 PostEarnings & High Win Rate Trade Tips - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is now a turning point for NeoGenomics IncIndex Update & Technical Pattern Based Buy Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

NeoGenomics reports Q2 revenue of $181.3mln, net loss of $45.1mln. - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Fort Myers cancer lab firm wins federal patent lawsuit - Business Observer

Sep 02, 2025
pulisher
Sep 02, 2025

Neogenomics shares fall 1.25% premarket after court rules in favor of patent invalidity. - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Natera (NTRA) Provides an Update on its Intellectual Property Litigation With NeoGenomics - MSN

Sep 02, 2025
pulisher
Sep 02, 2025

Applying big data sentiment scoring on NeoGenomics Inc.Dollar Strength & Risk Managed Investment Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Does NeoGenomics Inc. meet Warren Buffett’s criteriaTrade Risk Summary & Daily Oversold Stock Bounce Ideas - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Will NeoGenomics Inc. outperform the market in YEARVolume Spike & Daily Chart Pattern Signals - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Real time social sentiment graph for NeoGenomics Inc.July 2025 Levels & Risk Adjusted Swing Trade Ideas - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Why is NeoGenomics Inc. stock going upCPI Data & Fast Entry Momentum Trade Alerts - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Technical Charts Suggest Momentum Shift in CCRN getLinesFromResByArray error: size == 0 - kangso.co.kr

Sep 01, 2025
pulisher
Sep 01, 2025

Full technical analysis of NeoGenomics Inc. stockJuly 2025 Market Mood & Long-Term Safe Investment Ideas - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

NeoGenomics rallies after court win in Natera patent dispute - MSN

Sep 01, 2025
pulisher
Sep 01, 2025

Applying big data sentiment scoring on NeoGenomics IncWeekly Trade Recap & High Conviction Investment Ideas - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Neogenomics Soars 21.64% on Legal Victory, Cancer Diagnostics Dominance - AInvest

Sep 01, 2025
pulisher
Sep 01, 2025

Is a relief rally coming for NeoGenomics Inc. holdersJuly 2025 Outlook & Growth Oriented Trade Recommendations - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

How to interpret RSI for NeoGenomics Inc. stockMarket Volume Report & Free High Accuracy Swing Entry Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

What’s next for NeoGenomics Inc. stock priceEarnings Recap Summary & Short-Term High Return Strategies - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Can NeoGenomics Inc. rally from current levelsEarnings Growth Report & Safe Entry Zone Identification - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Has NeoGenomics Inc. formed a bullish divergenceGap Down & Weekly Setup with High ROI Potential - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Signal strength of NeoGenomics Inc. stock in tech scannersInsider Selling & Fast Gain Swing Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Automated trading signals detected on NeoGenomics Inc.July 2025 Trends & Consistent Profit Trade Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Analysts Backtest Strategies on NeoGenomics Inc. With Promising Results getLinesFromResByArray error: size == 0 - thegnnews.com

Aug 31, 2025
pulisher
Aug 31, 2025

NeoGenomics Sees Price Target Reduced Amidst Steady Optimism - StocksToTrade

Aug 31, 2025
pulisher
Aug 31, 2025

NeoGenomics Inc. stock outlook for YEARPortfolio Profit Report & Fast Gain Swing Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Can swing trading help recover from NeoGenomics Inc. lossesTrade Exit Summary & Low Risk High Win Rate Picks - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Can NeoGenomics Inc. deliver alphaWeekly Stock Recap & Fast Gain Swing Trade Alerts - sundaytimes.kr

Aug 30, 2025
pulisher
Aug 30, 2025

Can volume confirm reversal in NeoGenomics Inc.2025 Winners & Losers & Real-Time Volume Trigger Notifications - Newser

Aug 30, 2025

Neogenomics Inc Azioni (NEO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research WAT
$291.94
price down icon 1.53%
diagnostics_research DGX
$177.66
price down icon 0.55%
diagnostics_research LH
$271.45
price down icon 0.81%
$169.41
price up icon 0.05%
diagnostics_research MTD
$1,269.26
price down icon 0.55%
diagnostics_research IQV
$181.50
price down icon 1.19%
Capitalizzazione:     |  Volume (24 ore):